Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Time to Buy?

Hypermarcas (OTCMKTS:HYPMY) shares gapped up before the market opened on Monday . The stock had previously closed at $3.96, but opened at $4.1125. Hypermarcas shares last traded at $4.1125, with a volume of 218 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

Hypermarcas Trading Down 0.7%

The stock has a fifty day moving average of $4.28 and a two-hundred day moving average of $4.39. The company has a market capitalization of $2.86 billion, a PE ratio of 8.46 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The business had revenue of $383.13 million for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Equities analysts forecast that Hypermarcas will post 0.53 EPS for the current year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.